Winslow Klaskala

1.6k total citations
44 papers, 1.2k citations indexed

About

Winslow Klaskala is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Winslow Klaskala has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 14 papers in Epidemiology and 12 papers in Infectious Diseases. Recurrent topics in Winslow Klaskala's work include Atrial Fibrillation Management and Outcomes (13 papers), Viral-associated cancers and disorders (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). Winslow Klaskala is often cited by papers focused on Atrial Fibrillation Management and Outcomes (13 papers), Viral-associated cancers and disorders (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). Winslow Klaskala collaborates with scholars based in United States, Zambia and Belgium. Winslow Klaskala's co-authors include Marianna K. Baum, Roger M. Mills, Arba L. Ager, John Lindo, Charles Wood, Adrian F. Hernandez, Charles D. Mitchell, Chipepo Kankasa, Carol Palmer and Rina Girard de Kaminsky and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Winslow Klaskala

43 papers receiving 1.1k citations

Peers

Winslow Klaskala
F. Raffi France
Daniel E. Nixon United States
Bruno Granwehr United States
Yoganand Chillarige United States
Vivian K. Kawai United States
F. Raffi France
Winslow Klaskala
Citations per year, relative to Winslow Klaskala Winslow Klaskala (= 1×) peers F. Raffi

Countries citing papers authored by Winslow Klaskala

Since Specialization
Citations

This map shows the geographic impact of Winslow Klaskala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winslow Klaskala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winslow Klaskala more than expected).

Fields of papers citing papers by Winslow Klaskala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winslow Klaskala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winslow Klaskala. The network helps show where Winslow Klaskala may publish in the future.

Co-authorship network of co-authors of Winslow Klaskala

This figure shows the co-authorship network connecting the top 25 collaborators of Winslow Klaskala. A scholar is included among the top collaborators of Winslow Klaskala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winslow Klaskala. Winslow Klaskala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Yee Weng, Gregg C. Fonarow, Xiaojuan Mi, et al.. (2013). TIME TO INTRAVENOUS THERAPY AND CLINICAL OUTCOMES IN OLDER PATIENTS PRESENTING WITH ACUTE DECOMPENSATED HEART FAILURE: AN ANALYSIS OF THE ADHERE REGISTRY EMERGENCY MODULE. Journal of the American College of Cardiology. 61(10). E622–E622. 1 indexed citations
2.
Chamberlain, Alanna M., Suzette J. Bielinski, Susan A. Weston, et al.. (2013). Atrial fibrillation in myocardial infarction patients: Impact on health care utilization. American Heart Journal. 166(4). 753–759. 5 indexed citations
4.
Hernandez, Adrian F., Bradley G. Hammill, Robb D. Kociol, et al.. (2013). Clinical Effectiveness of Anticoagulation Therapy Among Older Patients With Heart Failure and Without Atrial Fibrillation: Findings From the ADHERE Registry Linked to Medicare Claims. Journal of Cardiac Failure. 19(6). 401–407. 6 indexed citations
5.
Piccini, Jonathan P., Yue Zhao, Benjamin A. Steinberg, et al.. (2013). Comparative Effectiveness of Pharmacotherapies for Prevention of Atrial Fibrillation Following Coronary Artery Bypass Surgery. The American Journal of Cardiology. 112(7). 954–960. 13 indexed citations
6.
Fosbøl, Emil Loldrup, Tracy Y. Wang, Shuang Li, et al.. (2013). Warfarin use among older atrial fibrillation patients with non–ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy. American Heart Journal. 166(5). 864–870. 41 indexed citations
7.
Fosbøl, Emil Loldrup, Tracy Y. Wang, Shuang Li, et al.. (2012). Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non–ST elevation myocardial infarction. American Heart Journal. 163(4). 720–728. 41 indexed citations
10.
Kwong, Louis M., Kristin D. Kistler, Roger M. Mills, Peter Wildgoose, & Winslow Klaskala. (2012). Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review. Expert Opinion on Pharmacotherapy. 13(3). 333–344. 20 indexed citations
11.
Hare, C. Bradley, Jonathan Morris, Alice Chu, et al.. (2005). Comparison of characteristics of treated and non‐treated patients with Hepatitis C infection. Pharmacoepidemiology and Drug Safety. 15(2). 71–76. 12 indexed citations
12.
Markowitz, Jacqueline, Elane M. Gutterman, David S. Hodes, & Winslow Klaskala. (2005). Factors associated with the initiation of alpha‐interferon treatment in Medicaid patients diagnosed with hepatitis C. Journal of Viral Hepatitis. 12(2). 176–185. 16 indexed citations
13.
Sullivan, Sean D., Donald M. Jensen, David Bernstein, et al.. (2004). Cost-Effectiveness of Combination Peginterferon alpha-2a and Ribavirin Compared With Interferon alpha-2b and Ribavirin in Patients With Chronic Hepatitis C. The American Journal of Gastroenterology. 99(8). 1490–1496. 47 indexed citations
15.
Klaskala, Winslow, Brad Brayfield, Chipepo Kankasa, et al.. (2004). Epidemiological characteristics of human herpesvirus‐8 infection in a large population of antenatal women in Zambia. Journal of Medical Virology. 75(1). 93–100. 34 indexed citations
16.
Brayfield, Brad, Chipepo Kankasa, Geoffrey Kwenda, et al.. (2003). Postnatal Human Herpesvirus 8 and Human Immunodeficiency Virus Type 1 Infection in Mothers and Infants from Zambia. The Journal of Infectious Diseases. 187(4). 559–568. 43 indexed citations
17.
Neary, Maureen P., et al.. (2003). Isotretinoin and antidepressant pharmacotherapy: A prescription sequence symmetry analysis. Journal of the American Academy of Dermatology. 49(3). 424–432. 69 indexed citations
18.
Klaskala, Winslow, et al.. (1999). Drug use and syphilis. Co-factors for HIV transmission among commercial sex workers in Guyana.. PubMed. 48(2). 52–6. 19 indexed citations
19.
Renjifo, Boris, Jason T. Blackard, Winslow Klaskala, et al.. (1999). HIV-1 subtype B in Honduras. Virus Research. 60(2). 191–197. 6 indexed citations
20.
Lindo, John, Arba L. Ager, Helena M. Solo‐Gabriele, et al.. (1998). Intestinal parasitic infections in human immunodeficiency virus (HIV)-positive and HIV-negative individuals in San Pedro Sula, Honduras.. American Journal of Tropical Medicine and Hygiene. 58(4). 431–435. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026